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AbstrAct
Diethylene glycol (DEG) is an uncommon cause of toxic alcohol poisoning. In the past, its ingestion in contaminated 
pharmaceutical products has resulted in mass outbreaks. We describe two isolated cases of unintentional DEG 
poisoning following the consumption of a shared alcoholic beverage and highlight the challenges that were confronted 
during the diagnostic work-up and management. Despite appropriate therapy, both cases had fatal outcomes, which 
emphasises the importance of early recognition of the condition and of instituting specific treatment. 
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INtrODUctION
Diethylene glycol (DEG) is an uncommon cause of toxic 
alcohol poisoning that is characterised by a fulminant and 
often fatal course [1-4]. Numerous epidemics have 
occurred throughout the world with children frequently 
affected due to the ingestion of pharmaceutical products 
in the syrup formulation [1,3-5]. We report on two 
isolated cases of ingestion of an unknown quantity of a 
contaminated, locally bottled, alcoholic beverage with 
characteristic clinical, laboratory and pathological features 
of DEG poisoning.
cAsE 1
A 34-year-old male presented with a 3-day history of 
feeling unwell, nausea, vomiting and confusion. At the 
peripheral hospital, he was found to have severe acute 
kidney injury (AKI) and was transferred to our centre 
for dialysis support. Due to his obtundation, no history 
could be obtained, and no collateral history was available 
at the time. Other than his cognitive impairment, the 
rest of the clinical examination was unremarkable.
Initial laboratory results revealed a high anion gap (AG) 
metabolic acidosis without a raised osmolal gap (OG) 
and severe renal impairment (see Table 1). A lumbar 
puncture was performed and the cerebrospinal fluid 
(CSF) was blood-stained but analysis revealed a very high 
protein concentration of 11.3 g/L.
A diagnosis of severe, unexplained AKI was made and 
haemodialysis was initiated due to clinical deterioration. 
A collateral history was eventually obtained from a rela-
tive who reported that he was well prior to attending a 
party 4 days prior to presentation. He had shared an 
alcoholic beverage with a female friend (case 2), who 
was also currently admitted to a peripheral hospital with 
similar findings.
He continued to deteriorate despite dialysis support and 
died two days later. An autopsy was performed that 
revealed centrilobular hepatic necrosis and renal cortical 
necrosis without any calcium oxalate crystals, excluding a 
diagnosis of ethylene glycol poisoning (EGP). 
cAsE 2
A 41-year-old female was referred from the same 
peripheral hospital with complaints of generalised abdo-
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9minal pain and diarrhoea. The patient reported that the 
symptoms had started one week prior to presentation, 
after sharing an alcoholic beverage with her partner 
(case 1). She noted that the beverage had tasted sweeter 
than usual. The gastrointestinal symptoms persisted with a 
progressive decline in urine volume.
She had HIV and was taking anti-retroviral therapy. There 
was no history of any pre-existing neurological or kidney 
disease, nor a history of alcohol dependence or abuse. 
Examination revealed that she was afebrile with a heart 
rate of 102 beats per minute, a blood pressure of 120/90 
mmHg and a respiratory rate of 20 breaths per minute. She 
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table 1. serum chemistry, blood gas and cerebrospinal fluid analysis.
Serum chemistry Reference range Case 1 Case 2
Sodium 135–147 mmol/L 138          126
Potassium 3.5–5.1 mmol/L 4.2 5.1
Chloride 101–109 mmol/L 60 95
Urea 2.6–7.0 mmol/L 51 38
Creatinine 49–90 µmol/L 1602 1430
Total bilirubin 5–21 µmol/L 9 –
Alanine transaminase 7–35 U/L 666 78
Lipase 13–60 U/L – 99
Glucose 4.1–5.9 mmol/L 6.4 5.5
Osmolality 275–295 mOsm/kgH2O 348 324
Osmolal gap <10 mOsm/kgH2O <10 17
Anion gap 7–16 mmol/L 62.4 32.0
Blood gas analysis
pH 7.36–7.44 7.40 7.30
PaO2 10.3–13.3 kPa 12.1 17.0
PaCO2 4.7–6.0 kPa 3.2 2.0
Bicarbonate 23–27 mmol/L 15.6 12.0
Lactate 0.5–1.0 mmol/L 2.7 1.4
CSF analysis
Protein 0.1–0.45 g/L 11.3 15.0
Glucose 2.2–3.9 mmol/L 6.6 4.7
RBC 0 per mm3 Blood-stained 1408
PMN leucocytes 0 per mm3 Blood-stained 12
Lymphocytes 0–10 per mm3 Blood-stained 37
India ink stain – Negative Negative
CLAT – Negative Negative
Abbreviations: CSF, cerebrospinal fluid; RBC, red blood cells; PMN, polymorphonuclear leukocytes; CLAT, cryptococcal latex agglutination test.
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was fully orientated with no focal neurological deficits. The 
remainder of the clinical examination was normal.   
Laboratory results revealed a high OG and a high AG 
metabolic acidosis, AKI and raised hepatic transaminases 
(see Table 1).  Due to her anuria, no specimen was available 
for urinalysis. 
A diagnosis of an unidentified toxic alcohol ingestion was 
suspected, possibly EGP. She was immediately started on 
haemodialysis. 
Three weeks following her presentation she developed 
new-onset bulbar palsy together with facial diplegia. She 
was also noted to have anisocoria, paralysis with reduced 
reflexes and autonomic dysfunction as evidenced by 
orthostatic hypotension, tachycardia and urinary retention. 
A non-contrasted computed tomography scan of the 
head was normal; however, the lumbar puncture revealed 
a very high CSF protein concentration of 15 g/L with a 
pleocytosis. Nerve conduction studies revealed absent 
motor responses in the lower limbs but with normal 
responses in the upper limbs. 
With the evolution of her neurological deficits a diagnosis 
of DEG poisoning was made. Six weeks following her initial 
presentation, she died despite treatment for nosocomial 
sepsis and continued dialysis support. An autopsy was 
performed that revealed similar findings to case 1.
DIscUssION
DEG is an uncommon cause of toxic alcohol poisoning. It 
is a colourless, odourless liquid with a sweet taste and is 
used as a solvent for water-insoluble chemicals. It is 
metabolised, in a similar fashion to other toxic alcohols, by 
the liver into its end-product of 2-hydroxyethoxyacetic 
acid (2-HEAA) with eventual renal elimination. This end-
product is thought to be responsible for the renal and 
nervous system toxicity [6,7]. 
The last documented outbreak in South Africa was 
reported in 1972 involving 7 children treated with over-
the-counter medications, Pronap and Plaxim [1]. During 
contemporary times, it tends to occur in developing 
countries with poor quality control measures, where 
DEG is used during the drug manufacturing process instead 
of more expensive, less toxic glycols such as propylene 
glycol [4,7].
Three distinct clinical phases of DEG poisoning have been 
reported, namely: phase 1 – early neurological and 
gastrointestinal symptoms; phase 2 – severe kidney failure 
and liver toxicity; and finally, phase 3 – neurological sequelae 
may evolve if the patient survives the phase 2 [4,8]. Case 2 
demonstrated all three phases. Gastrointestinal symptoms 
include abdominal pain, nausea, vomiting and diarrhoea. 
These symptoms may have a delayed onset if the liquid is 
co-ingested with a significant quantity of ethanol. This may 
explain the late presentation of both our cases. 
Phase 2 usually follows 1–3 days after ingestion and its 
inception is marked by the onset of AKI with eventual 
anuria due to renal cortical necrosis. Moderate elevations 
of hepatic transaminases usually accompany the renal 
injury. Severe AKI and a mild hepatitis were present in 
case 2. Of note was the normal venous lactate concentra-
tion on a point-of-care blood gas analysis. While ethylene 
glycol poisoning (EGP) may produce similar features, the 
normal serum lactate, which is falsely elevated in EGP 
when measured using the enzymatic method [9,10], as well 
as the mild hepatitis, were initial clues of an alternative 
toxic alcohol ingestion [8,11]. Also, autopsy findings were 
identical to the cases described previously in South 
Africa [1] with the absence of calcium oxalate deposits 
in parenchymal tissue, normally seen in EGP, excluding 
this latter diagnosis.
The development of neurological deficits marks the onset 
of the final phase. This phase occurs 5–10 days after 
ingestion. The peripheral nervous system is predominantly 
affected with involvement of cranial nerves that presents 
with symptoms and signs of diplopia, facial diplegia and 
bulbar palsy. Peripheral neuropathies of the upper and/or 
lower limbs may result in quadri- and paraparesis. Case 2 
demonstrated most of these neurological features. These 
findings are rare in other toxic alcohol poisonings [4,5,11]. 
The offending alcoholic beverage was never recovered to 
confirm DEG contamination. Although alcoholic beverages 
have been reported to be contaminated with DEG, cough 
mixtures, acetaminophen syrup and sedatives are most 
frequently seen with mass outbreaks [4,5]. Contamination 
of these pharmaceutical products resulted in epidemics of 
DEG poisoning. As it usually does not occur in isolation, a 
high clinical index of suspicion should be maintained when 
multiple cases present with inebriation together with 
gastrointestinal upset, followed by the rapid development 
of AKI. 
Direct measurements of blood toxic alcohol levels are 
frequently not available; however, a raised serum OG 
(difference between the measured and calculated serum 
osmolality) is the first step to early diagnosis. As was seen 
in our second case, a mild OG was still present a few days 
following ingestion. However, compared to other toxic 
alcohols, DEG poisoning is least likely to increase the 
serum OG and can frequently be normal at first presenta-
tion [4,8]. The median OG in one outbreak was reported 
to be only 7.6 mOsm/kg [5]. When freezing-point depres-
sion is used to measure serum osmolality, high molecular 
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weight substances will have a lower serum osmolality per 
unit concentration. As DEG consists of two ethylene glycol 
molecules linked together by an ether bond, it has a higher 
molecular weight relative to other toxic alcohols and 
therefore the OG may be normal or only modestly raised 
as in our second case. Another diagnostic clue to DEG 
poisoning is a severely elevated CSF protein concentration 
as was found in both of our cases. The Panama epidemic of 
2006 reported that the CSF protein concentration ranged 
from 0.39–5.17 g/L without any pleocytosis [5].   
Other than supportive care such as the administration of 
sodium bicarbonate for severe metabolic acidosis, benzo-
diazepines for seizures and intravenous fluids with or 
without vasopressor support, the aim of therapy is directed 
at reducing the conversion of DEG into its toxic metabolite, 
2-HEAA. This is achieved by the administration of either 
fomepizole or ethanol, which acts as an inhibitor or 
competitive substrate for the enzyme, alcohol dehydro-
genase, respectively [4]. The presence of an OG implies 
that the toxic alcohol is still present and therefore the 
administration of the latter drugs may still be of benefit in 
preventing its conversion to 2-HEAA. Since fomepizole is 
not available in SA, ethanol should be used. Elimination of 
DEG and 2-HEAA can be achieved with haemodialysis or 
haemodiafiltration. As with our cases, this is the only option 
available when patients present late with established renal 
failure and anuria.    
Even with the best supportive care, the overall prognosis 
of DEG poisoning is poor. Until 2008, a total of 5/13 
documented outbreaks reported 100% mortality [5]. A 
lethal dose of DEG is ~1 ml/kg [4]. We suspect that the 
delayed presentation to hospital contributed largely to the 
eventual death of our cases. Those that require dialysis and 
survive inevitably become dialysis dependent and may 
have permanent neurological complications.  
cONclUsIONs
DEG is an uncommon cause of toxic alcohol poisoning and 
is usually associated with mass outbreaks. Hallmark clinical 
features include severe, oligo-anuric acute kidney injury 
together with a mild hepatitis and eventually severe peri-
pheral neuropathies. Early diagnosis and initiation of 
therapy may improve survival; however, mortality remains 
high. A continued search for the root cause of contaminated 
products is mandatory to prevent larger outbreaks. 
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